Ann M. Arvin

2 ta ish

VIR Biotechnology (United States)

1. A perspective on potential antibody-dependent enhancement of SARS-CoV-2

   Ann M. Arvin, Katja Fink, Michael Schmid +6

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.571383

2. After the pandemic: perspectives on the future trajectory of COVID-19

   Amalio Telenti, Ann M. Arvin, Lawrence Corey +7

   Sharh maqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.011503